Reata Pharmaceuticals Inc buy Global_Player
Summary
This prediction ended on 02.04.22 with a price of €31.80. The prediction had a final performance of 25.20%. Global_Player has 50% into this predictionReata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on identifying, developing, and commercializing novel therapeutics for patients with severe and life-threatening diseases. The company's primary business areas include drug discovery and development in fields such as cardiovascular, fibrotic, mitochondrial, and neurodegenerative diseases. With a strong emphasis on research and innovation, Reata Pharmaceuticals seeks to deliver cutting-edge treatments that address unmet medical needs, improve patient outcomes, and significantly impact the lives of those suffering from rare and debilitating conditions. As a publicly traded company, Reata Pharmaceuticals is listed on the NASDAQ stock exchange under the ticker symbol "RETA."
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reata Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% | 61.530% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% | 97.770% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% | 48.713% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% | 62.430% |
According to Global_Player what are the pros and cons of Reata Pharmaceuticals Inc for the foreseeable future?
Pros
Cons
Comments by Global_Player for this prediction
In the thread Reata Pharmaceuticals Inc diskutieren
In the thread Trading Reata Pharmaceuticals Inc
Stopped prediction by Global_Player for Reata Pharmaceuticals Inc
Reata Pharmaceuticals Inc
26.02.23
26.02.24
03.03.23
